Prospects for further US employment and profits growth are improving, but the US is now running the 3rd highest infection rate in the world.  In infection hotspot states, governors are relying on falling mortality as the reason to make only minor policy adjustments.  This week, we look at why mortality is diverging from infections and hospitalizations, and more broadly, at whether a US scientific trust gap has played a role in the recent infection surge.  To conclude: some client Q&A on last week’s Eye on the Market energy paper. 

Continue reading